International ME/CFS Conference 2025
Videos
Charité – Universitätsmedizin Berlin and the ME/CFS Research Foundation organised the “International ME/CFS Conference 2025“ on 12-13 May 2025 in Berlin. The event was directed at medical professionals, researchers and interdisciplinary experts in the fields of medicine and biology.
In addition to presentations, the two-day conference featured more than 40 scientific posters. Among the posters, 3 outstanding contributions were awarded poster prizes by the ME/CFS Research Foundation via a scientific jury.
Videos, slides and short summaries (the latter provided in cooperation with the German Association for ME/CFS) of the presentations from the conference can be accessed on this website by clicking on one the presentation titles below. Some videos and slides may not be available or may be released later, due to limitations regarding unpublished data from ongoing research.
All presentations were held in English. For the videos, automatically generated subtitles are available via Youtube.
Introduction
Welcome
Carmen Scheibenbogen
Charité – Universitätsmedizin Berlin, Germany
Infection-Associated Chronic Illnesses (IACIs)
David Putrino
Icahn School of Medicine at Mount Sinai, New York, USA
Where have we made progress?
Carmen Scheibenbogen
Charité – Universitätsmedizin Berlin, Germany
Care for ME/CFS
PEDNET-LC
Uta Behrends
Technical University of Munich (TUM) Hospital and Munich Schwabing Clinic, Germany
Reference Center for Post-viral Syndromes
Kathryn Hoffmann
Medical University of Vienna, Austria
The Akureyri Clinic
Fridbjörn Sigurdsson
Landspitali - University Hospital, Reykjavik, Iceland
CFS_CARE
Claudia Kedor
Charité – Universitätsmedizin Berlin, Germany
Clinical care for ME/CFS
Michael Stingl
Dr. Michael Stingl Private Practice, Austria
Long/Post-COVID Off-Label-Use of Drugs
Bernhard Wörmann
Charité – Universitätsmedizin Berlin, Germany
Severe, and very severe ME/CFS in Norway
Kristian Sommerfelt
University of Bergen, Norway
Posters
Functional Connectivity Alterations in ME/CFS
Guido Cammà
Charité – Universitätsmedizin Berlin, Germany
Reduced Abundance of Gut Bacteria in ME/CFS
Wiebke Löhden
Kiel University (CAU), Germany
Handgrip Strength in Children with ME/CFS
Lorenz Mihatsch
Technical University of Munich (TUM), Germany
Raman Spectroscopic Profiling of Immune Cells
Christian Puta
Friedrich Schiller University Jena, Germany
Skeletal Muscle in ME/CFS and Post-COVID
Anouk Slaghekke
Vrije Universiteit (VU) Amsterdam, Netherlands
Understanding I: Cardiovascular dysregulation and mitochondrial pathology
Circulatory dysfunction in ME/CFS
David Systrom
Brigham and Women's Hospital and Harvard Medical School, Boston, USA
Skeletal muscle alteration in Long COVID and ME/CFS
Rob Wust
Vrije Universiteit (VU) Amsterdam, Netherlands
Changes in Mitochondria in Muscle
Jürgen Steinacker
Institute of Rehabilitation Medicine Research at Ulm University, Germany
Mechanisms of Post-Exertional Malaise (PEM)
Christian Puta
Friedrich Schiller University Jena, Germany
Changed patterns of blood metabolites
Karl Johan Tronstad
University of Bergen, Norway
Understanding II: Immune dysregulation and autoimmunity
Autoimmunity as a cause of ME/CFS
Jeroen den Dunnen
Amsterdam University Medical Center (UMC), Netherlands
GPCR autoantibodies and brain alterations
Takashi Yamamura
National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
Autoantibodies mimicking EBV sequences
Franziska Sotzny
Charité – Universitätsmedizin Berlin, Germany
Autoantibodies to neuronal antigens
Christiana Franke
Charité – Universitätsmedizin Berlin, Germany
T and B cell responses in ME/CFS
Birgit Sawitzki
Charité – Universitätsmedizin Berlin, Germany
Transcriptome analysis in ME/CFS
Anna Aschenbrenner
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
Treatment I: Clinical trials targeting autoantibodies
Drug treatment - What have we learned since 2007?
Olav Mella
University of Bergen, Norway
Plasma cell targeting by daratumumab in ME/CFS
Øystein Fluge
University of Bergen, Norway
B cell depletion targeting CD19
Judith Bellmann-Strobl
Charité - University Medicine Berlin, Germany
Rituximab trial in Japan
Wakiro Sato
National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
Efficacy of repeated immunoadsorption in ME/CFS
Elisa Stein
Charité – Universitätsmedizin Berlin, Germany
Immunoadsorption in severe ME/CFS patients
Georg Schlieper
Dialysis Hannover - Center for Kidney, Hypertension and Metabolic Diseases, Germany
Treatment II: Clinical trials
IgG therapy in ME/CFS and Post-COVID Syndrome
Nina Babel
Charité – Universitätsmedizin Berlin, Germany
Hyperbaric Oxygen Therapy (HBOT) in ME/CFS
Laura Kim
Charité – Universitätsmedizin Berlin, Germany
Anhydrous Enol-Oxaloacetate Treatment of ME/CFS
Alan Cash
Terra Biological LLC, USA
Viral persistence in Post-COVID Syndromes
Michael Peluso
University of California San Francisco (UCSF), USA
LDN and Mestinon in ME/CFS and Long COVID
David Systrom
Brigham and Women's Hospital and Harvard Medical School, Boston, USA
Low-dose Rapamycin for Long COVID
David Putrino
Icahn School of Medicine at Mount Sinai, New York, USA
Exercise Intolerance and Therapeutic Strategy
Klaus Wirth
Mitodicure GmbH, Germany
More Information
Sponsors